Early Experience with Full-scope Shared-care Teleglaucoma in Canada.

Precis Large Canadian full-scope, shared-care teleglaucoma facilitates efficient management and diversion of medically-stable patients away from overburdened subspecialty clinics while allowing patients the convenience of shorter travel, shorter wait time, and continuity with one provider. This report shares Care1 protocol, early patient characteristics, and quality data. Purpose This paper describes early experience with Care1, a large full-scope, shared-care teleglaucoma program. Optometrists located in high-demand locations saw patients in-person, acquired clinical history, performed physical examination, organized diagnostic testing, then uploaded data to a proprietary online platform where they were able to collaborate with participating ophthalmologists to make plans for patient care. Methods The Care1 database was queried for all patients with a diagnosis of glaucoma or glaucoma suspect seen between February 2016 and March 2017. Clinical characteristics like diagnosis, ocular medication history, best corrected visual acuity, intraocular pressure, cup-to-disc ratios, optical coherence tomography imaging results, and central corneal thickness were collected. Quality metrics studied included rates of referral to an in-person ophthalmologist and consistency of cup-to-disc assessments between in-person optometrists and remote ophthalmologists. Results 4070 patients received care at a Care1 teleophthalmology site in two provinces for glaucoma assessment from February 2016 to March 2017. The population was 55.1% female, and the average age was 57.8 years. 97.3% of patients had a best-corrected visual acuity between 20/20 and 20/40. 3.3% had an intraocular pressure greater than 26. An in-person consultation with an ophthalmologist was recommended for 1.9% of patients. Conclusion Early experience with this full-scope, shared-care teleglaucoma program in Canada indicates it is a convenient, collaborative model of care for glaucoma-suspects and medically stable glaucoma patients.